Mitchell P. Kopin 13D/13G Filings for Dermata Therapeutics, Inc. (DRMA)

Mitchell P. Kopin 13D and 13G filings for Dermata Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-13
4:40 pm
Purchase
2026-03-3113GDERMATA THERAPEUTICS INC P
DRMA
Mitchell P. Kopin211,246
4.990%
64,187increase
(+43.65%)
Filing